LEADER 04729nam 2200649Ia 450 001 9910454824603321 005 20200520144314.0 010 $a1-60741-682-4 035 $a(CKB)1000000000786444 035 $a(EBL)3018294 035 $a(SSID)ssj0000119202 035 $a(PQKBManifestationID)11134331 035 $a(PQKBTitleCode)TC0000119202 035 $a(PQKBWorkID)10055959 035 $a(PQKB)10871485 035 $a(MiAaPQ)EBC3018294 035 $a(Au-PeEL)EBL3018294 035 $a(CaPaEBR)ebr10660155 035 $a(OCoLC)847023476 035 $a(EXLCZ)991000000000786444 100 $a20081027d2009 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aCell, gene, and molecular therapy$b[electronic resource] $enew concepts /$fViroj Wiwanitkit 210 $aHauppauge, NY $cNova Science Publishers$dc2009 215 $a1 online resource (205 p.) 300 $aDescription based upon print version of record. 311 $a1-60692-532-6 320 $aIncludes bibliographical references and index. 327 $a""CELL, GENE AND MOLECULAR THERAPY: NEW CONCEPTS ""; ""CONTENTS ""; ""PREFACE ""; "" BASIC PRINCIPLE OF MEDICAL TREATMENT ""; ""HEALTHY AND DISEASE ""; ""A. General Concept ""; ""B. Health and Nutrition ""; ""C. Health and Welfare ""; ""D. Nutrition and Welfare ""; ""E. Trade and Welfare [16-17] ""; ""PUBLIC HEALTH CONCERN FOR PEOPLE IN THE RURAL COMMUNITY ""; ""A. Introduction ""; ""B. Consideration on Public Health Policy ""; ""C. Economic Development and Rural Health [24-25] ""; ""CLASSIFICATION OF DISEASES ""; ""FADE OF DISEASE ""; ""HOW TO TREAT? ""; ""REFERENCES ""; ""NANOTHERAPY "" 327 $a""INTRODUCTION TO NANOSCIENCE [1-7] """"WHY a???NANOTHERAPYa???? [12-16] ""; ""NANOSURGERY AND NANODENTISTRY ""; ""GENE THERAPY AND NANOBIOTECHNOLOGY ""; ""STEM CELL THERAPY, TISSUE ENGINEERING AND NANOBIOTECHNOLOGY ""; ""APPLICATION BY NANOPHARMACOLOGY ""; ""A. Genome Sequence Analysis ""; ""B. Microarrays ""; ""C. Proteomics Approach and High-Throughput Cloning ""; ""D. Bioinformatics Database Tools and Computational Vaccinology ""; ""NANOTECHNOLOGY AND DRUG DELIVERY ""; ""NANOVACCINOLOGY ""; ""ETHICAL ASPECT OF NANOTECHNOLOGY ""; ""REFERENCES "" 327 $a"" QUANTUM THERAPY AS WELL AS PHOTON THERAPY """"WHAT IS a???QUANTUMa???? ""; ""QUANTUM DIAGNOSIS: STAGE BEFORE TREATMENT ""; ""QUANTUM TREATMENT ""; ""PHOTON THERAPY ""; ""REFERENCES""; ""TISSUE ENGINEERING AND MEDICAL BIOPOLYMER APPLICATION""; ""APPLICATION OF ENGINEERING IN BIOLOGY ""; ""CONCEPT OF RECONSTRUCTION AND REGENERATIVE MEDICINE ""; ""SOME IMPORTANT REPORTS ON RECONSTRUCTIVE AND REGENERATIVE MEDICINE ""; ""WHY ANATOMICAL LOST NEEDS THERAPY? ""; ""TISSUE ENGINEERING ""; ""MEDICAL BIOPOLYMER APPLICATION ""; ""REFERENCES ""; "" TRANSPLANTATION IN MEDICINE "" 327 $a""TRANSPLANTATION: WHAT IS IT? """"BEFORE TRANSPLANTATION ""; ""ORGAN TRANSPLANTATION ""; ""A. Heart Transplantation ""; ""B. Lung Transplantation ""; ""C. Kidney Transplantation ""; ""D. Liver Transplantation ""; ""AFTER TRANSPLANTATION ""; ""REFERENCES ""; "" ADVENT IN RADIOTHERAPY, RADIOINTERVENTION AND RADIOSURGERY""; ""INTRODUCTION TO RADIOLOGY ""; ""RADIOTHERAPY ""; ""a) Classical Radiotherapy ""; "" b) Brachytherapy ""; ""c) Radioactive Substance Ingestion ""; ""RADIOINTERVENTION ""; ""RADIOSURGERY ""; ""REFERENCES ""; "" STEM CELL THERAPY ""; ""BEGINNING OF LIFE [1-3] "" 327 $a""BASIC CONCEPTS OF STEM CELL THERAPY """" MEDICAL ETHICS FOR STEM CELL THERAPY ""; ""CORD BLOOD STEM CELL COLLECTION ""; ""A. General Introduction ""; ""B. Cord Blood Collection Procedure ""; ""C. Cord Blood Banking ""; ""TRANSCIPTION FACTOR BINDING SITE E2F TRANSCRIPTION FACTOR: A PREDICTION ""; ""REFERENCES ""; "" ADVENT IN TRANSFUSION MEDICINE ""; ""INTRODUCTION TO BLOOD COMPONENT IN MEDICINE [1]""; ""A. Introduction ""; ""B. Risk of Transfusions ""; ""C. Indications for Transfusions ""; ""D. Blood Component from Donation ""; ""BLOOD TRANSFUSION FOR NEWBORN "" 327 $a""A. Whole Blood Transfusion "" 606 $aTherapeutics, Experimental 606 $aCellular therapy 606 $aImmunotherapy 606 $aGene therapy 608 $aElectronic books. 615 0$aTherapeutics, Experimental. 615 0$aCellular therapy. 615 0$aImmunotherapy. 615 0$aGene therapy. 676 $a615.8/95 676 $a370.9667/09045 700 $aViroj Wiwanitkit$0859676 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910454824603321 996 $aCell, gene, and molecular therapy$92476505 997 $aUNINA LEADER 03295oam 2200505zu 450 001 9910131300303321 005 20210807005001.0 010 $a2-8218-5333-5 024 7 $a10.4000/books.puam.428 035 $a(CKB)3710000000395814 035 $a(SSID)ssj0001493694 035 $a(PQKBManifestationID)12620534 035 $a(PQKBTitleCode)TC0001493694 035 $a(PQKBWorkID)11516099 035 $a(PQKB)11613978 035 $a(FrMaCLE)OB-puam-428 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/59730 035 $a(PPN)185661416 035 $a(oapen)doab59730 035 $a(EXLCZ)993710000000395814 100 $a20160829d2009 uy 101 0 $afre 135 $auu||||||m|||| 181 $ctxt 182 $cc 183 $acr 200 14$aLes Sources des Obligations 210 $cPresses universitaires d?Aix-Marseille$d2009 210 31$a[Place of publication not identified]$cPresses universitaires d'Aix Marseille$d2009 215 $a1 online resource (612 p.) 300 $aBibliographic Level Mode of Issuance: Monograph 311 08$a2-7314-0673-9 330 $aNotion plurale, la source des obligations se décompose en source formelle, source technique et source substantielle. Les sources formelles désignent le fondement juridique à partir duquel seront dégagés les sources techniques, fruit de l?interprétation judiciaire. Les sources substantielles ont été définies comme les conditions concrètes de naissance de l?obligation. Nées de l?application des notions techniques réalisées par les magistrats, elles s?articulent autour de la liberté du débiteur et la protection du créancier. L?approche classique a été définie comme la politique qui consacre la liberté du débiteur. Contenue en l?article 1370 du Code civil, elle plonge ses racines dans le passé et s?illustre aujourd?hui à travers de nombreux concepts. À l?opposé, l?approche moderne fait prévaloir la protection du créancier. Consacrée indirectement, elle laisse intact l?ordre technique existant et s?élabore à partir d?applications renouvelées des notions. Consacrée directement, elle donnera naissance à de nouvelles notions dont certaines recevront une traduction formelle. Une nouvelle approche de la liberté est souhaitable. L?acte juridique a été redéfini comme la libre création d?une croyance légitime. Le fait juridique consiste en la création dommageable d?un risque anormal. En chacune de ces sources, l?expression de la liberté est appréciée en la personne du débiteur tandis que le produit de la liberté est évalué en la personne du créancier. Par ailleurs, l?approche libérale fait aussi l?objet d?un dépassement. À la faveur de celui-ci, l?obligation se traduira par une charge individuelle définitive, d?une part, et une charge collective finale, d?autre part. 610 $aresponsabilité civile 610 $acontrat 610 $ahistoire du droit français 610 $aobligation (droit) 610 $aacte juridique 610 $aCode civil 700 $aObellianne$b Stephane$0973772 801 0$bPQKB 906 $aBOOK 912 $a9910131300303321 996 $aLes Sources des Obligations$92216248 997 $aUNINA